209 related articles for article (PubMed ID: 342602)
21. Analysis of low natural killer cell activity in 89Sr-treated mice.
Mellen PF; Lust JA; Bennett M; Kumar V
Eur J Immunol; 1982 May; 12(5):442-5. PubMed ID: 6212259
[TBL] [Abstract][Full Text] [Related]
22. Regulation of natural killer cell production in bone marrow of mice: no evidence for negative feedback control.
Bilge A; Pollack SB
Nat Immun; 1992; 11(3):156-66. PubMed ID: 1392403
[TBL] [Abstract][Full Text] [Related]
23. Role of suppressor cells in the decline of natural killer cell activity in estrogen-treated mice.
Milisauskas VK; Cudkowicz G; Nakamura I
Cancer Res; 1983 Nov; 43(11):5240-3. PubMed ID: 6225513
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
[TBL] [Abstract][Full Text] [Related]
25. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K
Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
[TBL] [Abstract][Full Text] [Related]
26. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
Afifi MS; Bennett M; Kumar V
Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
[TBL] [Abstract][Full Text] [Related]
27. Suppression of natural killer cell activity in infant mice occurs after target cell binding.
Dussault I; Miller SC
Nat Immun; 1995; 14(1):35-43. PubMed ID: 7599460
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of NK cell generation by Corynebacterium parvum.
Piccoli M; Santoni G; Santoni A; Frati L; Herberman RB; Chirigos MA
Immunopharmacol Immunotoxicol; 1991; 13(4):513-29. PubMed ID: 1723083
[TBL] [Abstract][Full Text] [Related]
29. Hypothalamic control of the generation of mature natural killer lymphocytes in bone marrow and spleen of the mouse.
Belluardo N; Mudó G; Cardile V; Migliorati G; Riccardi C; Cella S; Bindoni M
Nat Immun Cell Growth Regul; 1990; 9(1):26-35. PubMed ID: 2184351
[TBL] [Abstract][Full Text] [Related]
30. Alteration in natural defense activity against NK-susceptible B16 melanoma cells after treatment with Corynebacterium parvum.
Karashima A; Taniguchi K; Yoshikai Y; Nomoto K
Immunobiology; 1991 Aug; 182(5):414-24. PubMed ID: 1916884
[TBL] [Abstract][Full Text] [Related]
31. Natural killer inhibitory substance produced by the peritoneal cells of patients with ovarian cancer.
Lichtenstein AK; Berek J; Zighelboim J
J Natl Cancer Inst; 1985 Feb; 74(2):349-55. PubMed ID: 3856049
[TBL] [Abstract][Full Text] [Related]
32. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
33. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of natural killer cell activity by a soluble substance released by rat peritoneal cells.
Zighelboim J; Lichtenstein A; Bick A; Mickel R
Cancer Res; 1983 May; 43(5):1984-9. PubMed ID: 6339046
[TBL] [Abstract][Full Text] [Related]
35. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities.
Reynolds CW; Brunda MJ; Holden HT; Herberman RB
J Natl Cancer Inst; 1981 May; 66(5):837-42. PubMed ID: 6164813
[TBL] [Abstract][Full Text] [Related]
36. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo.
Kung SK; Miller RG
J Immunol; 1997 Mar; 158(6):2616-26. PubMed ID: 9058794
[TBL] [Abstract][Full Text] [Related]
37. Recognition and regulation of progenitor marrow elements by NK cells in the mouse.
O'Brien T; Kendra J; Stephens H; Knight R; Barrett AJ
Immunology; 1983 Aug; 49(4):717-25. PubMed ID: 6192081
[TBL] [Abstract][Full Text] [Related]
38. Role of lymphokine-activated killer cells as mediators of veto and natural suppression.
Azuma E; Kaplan J
J Immunol; 1988 Oct; 141(8):2601-6. PubMed ID: 3171179
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
[TBL] [Abstract][Full Text] [Related]
40. Population dynamics of natural killer cells and T lymphocytes in murine spleen and bone marrow during the development of erythroleukemia: the effect of indomethacin.
Miller SC; Christopher FL; Dussault I
Nat Immun; 1992; 11(2):78-91. PubMed ID: 1498521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
